Parallax Volatility Advisers
UTHR icon

Parallax Volatility Advisers’s United Therapeutics UTHR Stock Holding History

Parallax Volatility Advisers’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-3,344
Closed -$1.18M – 2166
2024
Q4 		$1.18M Buy
+3,344
New +$1.23M ﹤0.01% 1286
2019
Q4 		– Sell
-5,650
Closed -$451K – 2665
2019
Q3 		$451K Buy
5,650
+5,256
+1,334% +$423K ﹤0.01% 1638
2019
Q2 		$31K Sell
394
-11
-3% -$1.03K ﹤0.01% 2044
2019
Q1 		$48K Sell
405
-14
-3% -$1.63K ﹤0.01% 2306
2018
Q4 		$46K Buy
+419
New +$48.6K ﹤0.01% 2174
2018
Q3 		– Sell
-477
Closed -$59K – 3637
2018
Q2 		$54K Buy
477
+2
+0.4% +$220 ﹤0.01% 1565
2018
Q1 		$53K Buy
475
+164
+53% +$20.8K ﹤0.01% 1532
2017
Q4 		$46K Buy
311
+263
+548% +$33.4K ﹤0.01% 3274
2017
Q3 		$6K Sell
48
-43,861
-100% -$5.6M ﹤0.01% 1836
2017
Q2 		$5.7M Buy
+43,909
New +$5.48M 0.01% 537

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Parallax Volatility Advisers's UTHR Position: Q1 2025 in Review

Parallax Volatility Advisers sold out of United Therapeutics (UTHR) in Q1 2025, closing a stake of 3,344 shares — an estimated $1.18M sold.

Parallax Volatility Advisers first reported a position in UTHR in Q2 2017 and held it in 10 quarters. The position peaked at $5.7M in Q2 2017. 671 funds tracked by Wall St. Rank hold UTHR as of Q1 2025.

  • Parallax Volatility Advisers reported no remaining United Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Parallax Volatility Advisers sold 3,344 United Therapeutics shares in Q1 2025, an estimated $1.18M.
  • Parallax Volatility Advisers first reported a position in United Therapeutics in Q2 2017 and held it in 10 quarters.
  • Parallax Volatility Advisers's United Therapeutics position peaked at $5.7M in Q2 2017.
  • 671 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2025.

Based on Parallax Volatility Advisers's 13F filing for Q1 2025, filed 15 May 2025.